Table 4.
Relationship between CTC levels before neoadjuvant therapy and pCR in 50 patients.
CTC status | Pathology results, n (%) | |
---|---|---|
pCR | non-pCR | |
TUMORFISHER system | ||
Positive | 20 (74.1%) | 7 (25.9%) |
Negative | 9 (39.1%) | 14 (60.9%) |
χ2 value | 6.226 | |
p value | 0.013 | |
CellSearch system | ||
Positive | 11 (73.3%) | 4 (26.7%) |
Negative | 18 (51.4%) | 14 (48.6%) |
χ2 value | 2.068 | |
p value | 0.15 |